During lytic
infection with Epstein-Barr virus (EBV), several viral lytic
proteins function to evade immune recognition or to actively suppress immune cells. An EBV lytic
transactivator, Zta, induces an immunosuppressive
cytokine interleukin 10 (IL-10) in B cells, but whether it regulates
IL-10 in the context of epithelial cells is unclear. In this study, we tested
nasopharyngeal carcinoma (NPC) cell lines and found that Zta did not induce
IL-10 in these epithelial cells. Interestingly, the
conditioned medium of Zta-expressing NPC cells enhanced
IL-10 production from monocytes. We further revealed that the IL-10-inducing effect involved at least two
immunomodulators that were upregulated by Zta and secreted from NPC cells:
granulocyte-macrophage colony-stimulating factor (
GM-CSF) and
prostaglandin E(2) (
PGE(2)). Zta was recruited to and activated the
GM-CSF promoter, thus upregulating
GM-CSF expression. Zta also activated the promoter of
cyclooxygenase-2 (COX-2), and Zta-induced COX-2 increased downstream
PGE(2) production. Cotreatment with
GM-CSF and
PGE(2) synergistically induced
IL-10 production from monocytes. The IL-10-inducing effect of the Zta-
conditioned medium was reduced when
GM-CSF or the COX-2/
PGE(2) pathway was blocked. The
conditioned medium of NPC cells with EBV lytic
infection showed a similar increase of
GM-CSF and
PGE(2) levels as well as the IL-10-inducing effect on monocytes, and knockdown of Zta abolished all the effects. Therefore, through Zta-induced
immunomodulators, EBV lytic
infection in NPC cells can direct bystander monocytes to produce
IL-10, which may be a novel way of EBV to promote local immunosuppression.